The document describes how Katherine Leon, suffering from spontaneous coronary artery dissection (SCAD), took to online forums and social media to connect with others experiencing SCAD and learn more about the condition. Through these online connections, Dr. Sharonne Hayes was able to launch a pilot research study on SCAD and recruit participants. The study demonstrated that patient-initiated online networks can effectively engage patients and recruit for research studies about rare conditions. Initial findings from the study were published in Mayo Clinic Proceedings in 2011. The future of research includes more active participation by patients in helping to advance understanding of their conditions.
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...Inspire
Presentation by Inspire CEO Brian Loew to Society of Clinical Research Associates (SoCRA), Harnessing Social Media to Advance Clinical Research conference, August 2, 2013
These are the slides for the one day School for Health and Care Radicals that Helen Bevan ran in Vancouver on 18th February as part of the British Columbia Quality Forum, organised by the BC Patient Safety and Quality Council
Beyond Privacy: Social Media’s Ethical Responsibility to the Clinical Trial P...Inspire
Presentation by Inspire CEO Brian Loew to Society of Clinical Research Associates (SoCRA), Harnessing Social Media to Advance Clinical Research conference, August 2, 2013
These are the slides for the one day School for Health and Care Radicals that Helen Bevan ran in Vancouver on 18th February as part of the British Columbia Quality Forum, organised by the BC Patient Safety and Quality Council
This presentation is part of the Digital Scholar Training Series at USC and CHLA.
Learn more about the initiative: http://sc-ctsi.org/digital-scholar/
News story: http://sc-ctsi.org/index.php/news/new-digital-scholar-training-initiative-helps-researchers-better-utilize-we#.VDhIWWK9mKU
This is a strategic advertising and marketing plan that was developed for The Iowa Organ Donor Network. I was part of a group that devised a social media campaign backed by primary and secondary research. Our goal was to devise a plan that increased organ donor registration in college students.
Expository Essay: Examples and Tips of a Proper Writing That Will Be .... How to write Excellent Expository Essays. College essay: Different types of expository essays. Expository Essays | Essays | Paragraph. The Expository Essay | Essays | Causality. Define expository essays - writingquizzes.web.fc2.com. Fascinating Expository Essay Format ~ Thatsnotus. How to Write an Expository Essay: Examples and 25 Topic Ideas - How to .... College essay: Expositiry essay. How to write a good expository essay math Altus - how to write an essay .... 100+ Essay Writing Examples | MS Word, PDF | Examples. ️ Whats an expository essay. Best Expository Essay Topics 2018 For .... 017 Examples Of Expository Writing For 5th Grade Inspirational Example .... (PDF) THE ARGUMENTATIVE-EXPOSITIVE ESSAY AS A LEARNING STRATEGY IN .... Expository Essay Structure - What is an Expository Essay - Guide for .... How to Write an Expository Essay? (16 Best Examples). Expository Essay | Essays | Cognition. literature review body paragraph structure. Characteristics of Expository Text | Essays | Writing. Reflection Essay: Descriptive expository essay. 6 Types of Expository Writing with Examples. Expository Essay - 6+ Examples, Format, Pdf | Examples. Expository essays. Expository Essay – Interpretative. 30 Examples Of Informative Writing in 2020 | Expository essay .... English worksheets: How to write a simple exposition essay about the .... Expository Essay. Persuasive Essay: Examples of expository writing for elementary students. 30 Expository Essay Topics and Writing Prompts - HelpfulPaper Blog. 001 Essay Example Expository Definition ~ Thatsnotus. Expository Essays. informative essay examples 5th grade - Google Search | School .... Difference Between Argumentative and Expository Essay Expositive Essay
Slides from today's ImproveCareNow community "Virtual House Party"...all about patient, family & clinician partnership to improve care and staying connected across the miles. Lessons for other improvement communities too!
These are the slides from Helen Bevan’s talk “ It’s time to rewrite the rules of change in health and care” to be given on 3rd September 2014 at the APAC Forum, Melbourne Australia.
The APAC Forum (1st to 3rd September 2014) is the premier healthcare conference in the Asia Pacific region. It offers innovative ideas and leading-edge solutions for clinicians, managers, policy-makers and academics seeking to deliver the highest quality healthcare with finite resources and seemingly infinite demand. More details at http://apacforum.com/
"It's time to rewrite the rules of change in healthcare" - a presentation that Helen Beven, Chief Transformation Officer with the Horizons group, NHS Improving Quality, made at Yale on 10 June 2014.
This is the summary of the talk:
As leaders of health and care, we are seeking to create change in a world where the power of hierarchy is diminishing and change is happening faster and becoming more disruptive. Many of the ways we have traditionally gone about improving health and care were designed in a different mindset for a different set of circumstances and increasingly, they won't work. This means a fundamental rethink about what organisational change means; who does it (many change agents, not just a few) where it happens (increasingly 'at the edge' of organisations and the skills and mindsets that change agents need. This also means embracing disruption and 'disruptors' in our health and care organisations so that innovation happens; no longer seeking to 'overcome resistance to change' but welcoming difference, diversity and dissent as core operating principles in our approach to change. The slides end with a call to action: join the movement of health and care leaders across the world who are rewriting the rules of change and leading change from the future for different results.
Rocking the boat and staying in it: a presentation for Healthcare Improvement...NHS Improving Quality
This is the presentation that Helen Bevan, Chief of Service Transformation at NHS Improving Quality, England made for Healthcare Improvement Scotland on 23rd September 2014
Autism and Life Transitions: Hard Lessons Learned & Taught as a Person-Center...Cheryl Ryan Chan
In December of 2015, I presented this webinar to members of the National Association for Dual Diagnoses (thenadd.org). I've been conducting Person-Centered Plans for 4 years, and over that time I've seen a number of disturbing trends around the lack of understanding and planning for preparedness in transitioning students; in particular, in the areas of independent skill building specific to the anticipated environment, and personal safety skills. I feel it's important to talk about what I've observed and how my team of co-facilitators and I have identified and tackled these issues within the PCP process. I hope that the "lessons learned" will assist people in planning for IEP/ISP goals that can help maximize success. I offer it free to anyone who would like to attend.
Exercise and cancer: How staying active can positively impact your health and...Inspire
In an hour-long webinar, nationally recognized exercise specialist Carol Michaels, MBA, ACE, ACSM discussed how maintaining an exercise program during cancer treatment and recovery can help patients to minimize treatment side effects, increase energy levels, and reduce stress, along with many other benefits. Inspire produced the educational webinar in partnership with the Bladder Cancer Advocacy Network, US TOO International, and ThyCa: Thyroid Cancer Survivors' Association.
Patient-centric social media for outcomes and pharmacovigilance consideration...Inspire
Through the use of de-identified Big Data from online patient forums open to healthcare providers, the pharmaceutical industry may glean useful insights into both the safety of existing products as well as future needs of patients. Post-marketing safety surveillance for pharmaceuticals currently relies on data from adverse event reports to companies or regulatory authorities, medical literature, and observational databases. Together these sources provide some insight into everyday product safety or risk, but the unique insight the patients themselves can offer is also highly desirable.
Using insights from a 2016 research project involving Inspire, GlaxoSmithKline (GSK) Pharmaceuticals, and Epidemico, an innovative informatics company, we are exploring the use of social listening data for pharmacovigilance and other R&D concerns. A core question is, “What valuable insights can we glean from social listening to help improve patients’ lives—whether through improved safety, more relevant clinical trials, or research and development of new treatment options?”
More Related Content
Similar to The promise of patient-initiated research
This presentation is part of the Digital Scholar Training Series at USC and CHLA.
Learn more about the initiative: http://sc-ctsi.org/digital-scholar/
News story: http://sc-ctsi.org/index.php/news/new-digital-scholar-training-initiative-helps-researchers-better-utilize-we#.VDhIWWK9mKU
This is a strategic advertising and marketing plan that was developed for The Iowa Organ Donor Network. I was part of a group that devised a social media campaign backed by primary and secondary research. Our goal was to devise a plan that increased organ donor registration in college students.
Expository Essay: Examples and Tips of a Proper Writing That Will Be .... How to write Excellent Expository Essays. College essay: Different types of expository essays. Expository Essays | Essays | Paragraph. The Expository Essay | Essays | Causality. Define expository essays - writingquizzes.web.fc2.com. Fascinating Expository Essay Format ~ Thatsnotus. How to Write an Expository Essay: Examples and 25 Topic Ideas - How to .... College essay: Expositiry essay. How to write a good expository essay math Altus - how to write an essay .... 100+ Essay Writing Examples | MS Word, PDF | Examples. ️ Whats an expository essay. Best Expository Essay Topics 2018 For .... 017 Examples Of Expository Writing For 5th Grade Inspirational Example .... (PDF) THE ARGUMENTATIVE-EXPOSITIVE ESSAY AS A LEARNING STRATEGY IN .... Expository Essay Structure - What is an Expository Essay - Guide for .... How to Write an Expository Essay? (16 Best Examples). Expository Essay | Essays | Cognition. literature review body paragraph structure. Characteristics of Expository Text | Essays | Writing. Reflection Essay: Descriptive expository essay. 6 Types of Expository Writing with Examples. Expository Essay - 6+ Examples, Format, Pdf | Examples. Expository essays. Expository Essay – Interpretative. 30 Examples Of Informative Writing in 2020 | Expository essay .... English worksheets: How to write a simple exposition essay about the .... Expository Essay. Persuasive Essay: Examples of expository writing for elementary students. 30 Expository Essay Topics and Writing Prompts - HelpfulPaper Blog. 001 Essay Example Expository Definition ~ Thatsnotus. Expository Essays. informative essay examples 5th grade - Google Search | School .... Difference Between Argumentative and Expository Essay Expositive Essay
Slides from today's ImproveCareNow community "Virtual House Party"...all about patient, family & clinician partnership to improve care and staying connected across the miles. Lessons for other improvement communities too!
These are the slides from Helen Bevan’s talk “ It’s time to rewrite the rules of change in health and care” to be given on 3rd September 2014 at the APAC Forum, Melbourne Australia.
The APAC Forum (1st to 3rd September 2014) is the premier healthcare conference in the Asia Pacific region. It offers innovative ideas and leading-edge solutions for clinicians, managers, policy-makers and academics seeking to deliver the highest quality healthcare with finite resources and seemingly infinite demand. More details at http://apacforum.com/
"It's time to rewrite the rules of change in healthcare" - a presentation that Helen Beven, Chief Transformation Officer with the Horizons group, NHS Improving Quality, made at Yale on 10 June 2014.
This is the summary of the talk:
As leaders of health and care, we are seeking to create change in a world where the power of hierarchy is diminishing and change is happening faster and becoming more disruptive. Many of the ways we have traditionally gone about improving health and care were designed in a different mindset for a different set of circumstances and increasingly, they won't work. This means a fundamental rethink about what organisational change means; who does it (many change agents, not just a few) where it happens (increasingly 'at the edge' of organisations and the skills and mindsets that change agents need. This also means embracing disruption and 'disruptors' in our health and care organisations so that innovation happens; no longer seeking to 'overcome resistance to change' but welcoming difference, diversity and dissent as core operating principles in our approach to change. The slides end with a call to action: join the movement of health and care leaders across the world who are rewriting the rules of change and leading change from the future for different results.
Rocking the boat and staying in it: a presentation for Healthcare Improvement...NHS Improving Quality
This is the presentation that Helen Bevan, Chief of Service Transformation at NHS Improving Quality, England made for Healthcare Improvement Scotland on 23rd September 2014
Autism and Life Transitions: Hard Lessons Learned & Taught as a Person-Center...Cheryl Ryan Chan
In December of 2015, I presented this webinar to members of the National Association for Dual Diagnoses (thenadd.org). I've been conducting Person-Centered Plans for 4 years, and over that time I've seen a number of disturbing trends around the lack of understanding and planning for preparedness in transitioning students; in particular, in the areas of independent skill building specific to the anticipated environment, and personal safety skills. I feel it's important to talk about what I've observed and how my team of co-facilitators and I have identified and tackled these issues within the PCP process. I hope that the "lessons learned" will assist people in planning for IEP/ISP goals that can help maximize success. I offer it free to anyone who would like to attend.
Exercise and cancer: How staying active can positively impact your health and...Inspire
In an hour-long webinar, nationally recognized exercise specialist Carol Michaels, MBA, ACE, ACSM discussed how maintaining an exercise program during cancer treatment and recovery can help patients to minimize treatment side effects, increase energy levels, and reduce stress, along with many other benefits. Inspire produced the educational webinar in partnership with the Bladder Cancer Advocacy Network, US TOO International, and ThyCa: Thyroid Cancer Survivors' Association.
Patient-centric social media for outcomes and pharmacovigilance consideration...Inspire
Through the use of de-identified Big Data from online patient forums open to healthcare providers, the pharmaceutical industry may glean useful insights into both the safety of existing products as well as future needs of patients. Post-marketing safety surveillance for pharmaceuticals currently relies on data from adverse event reports to companies or regulatory authorities, medical literature, and observational databases. Together these sources provide some insight into everyday product safety or risk, but the unique insight the patients themselves can offer is also highly desirable.
Using insights from a 2016 research project involving Inspire, GlaxoSmithKline (GSK) Pharmaceuticals, and Epidemico, an innovative informatics company, we are exploring the use of social listening data for pharmacovigilance and other R&D concerns. A core question is, “What valuable insights can we glean from social listening to help improve patients’ lives—whether through improved safety, more relevant clinical trials, or research and development of new treatment options?”
Successfully Navigating the Parent Landmines in the NICU Inspire
Deb Discenza of PreemieWorld and the Inspire Preemie Support Community, presents at the 9th Council of International Neonatal Nurses Conference (COINN), in August 2016.
Support Without Borders: The Ovarian Cancer Online CommunityInspire
Inspire CEO Brian Loew presents online research data to the national conference of the Ovarian Cancer Research Fund Alliance (OCRFA), an Inspire partner. The conference session took place July 10, 2016, in Washington, DC.
Experts by Experience 2016: A compilation of patient storiesInspire
In cooperation with Stanford Medicine, Inspire presents the special report, "Experts by Experience 2016: A compilation of patient stories," the fourth in an ongoing series.
Optimize Social Listening and Monitoring to Uncover Unmet Consumer NeedsInspire
Dave Taylor, director of research at Inspire, discusses ways that pharmaceutical and biotech companies can appropriately and effectively leverage social listening and monitoring. Taylor presented at the CBI BioPharma Social Media and Digital Platforms conference in February 2016 in Philadelphia, PA.
The "Pulmonary Fibrosis Patient/Caregiver Experience Survey" explored the experiences of people affected by pulmonary fibrosis. Inspire conducted the survey in cooperation with its partner, the Pulmonary Fibrosis Foundation (PFF). Inspire CEO Brian Loew presented the findings during the PFF Summit in Nov. 2015 in Washington, DC.
Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product LaunchInspire
Incorporate Patient Participation – Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product Launch
Presentation by Inspire Research Director Dave Taylor at Evidence for Value-Based Programs conference
August 12, 2015
What Do Patients Really Want Out Of Adherence Technology?Inspire
Drawing insights from the 13,000-response Inspire Annual Survey, Dave Taylor, Inspire's director of research, presented at CBI’s Patient Adherence (PAAS) conference in Philadelphia, PA, in June 2015.
Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Sup...Inspire
Inspire CEO Brian Loew presented, "Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Support Community," at the June 2015 annual conference of nonprofit advocacy organization Mental Health America.
Insights into the e-Patient: An Analysis of the Inspire Annual SurveyInspire
"Insights into the e-Patient: An Analysis of the Inspire Annual Survey" was a presentation that Inspire's Dave Taylor made in May 2015 to the iPharma conference
Experts by Experience 2015: A compilation of patients’ storiesInspire
In cooperation with Stanford Medicine, Inspire presents "Experts by Experience 2015: A compilation of patients’ stories." The special report is the third in an ongoing series.
TalkPsoriasis is the largest online support community of people impacted by psoriasis or psoriatic arthritis. Sponsored by the National Psoriasis Foundation and Inspire, TalkPsoriasis is an open and encouraging environment where people affected by psoriasis or psoriatic arthritis can connect, exchange information, and meet friends.
Voice of the Empowered Patient: An Analysis of the Inspire Annual SurveyInspire
Inspire teamed with the trade organization Biotechnology Industry Organization for the seminar, “Connecting With the Empowered Patient in the Digital Age,” held Feb. 2015 at BIO headquarters in Washington, DC. The event brought together leaders from the patient advocacy community and life sciences industry to discuss how social media can be utilized to empower patients and engage advocates.
Inspire's Research Director Dave Taylor led the session, "Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey."
Real World Takeaway Strategies for Successful PartnershipsInspire
Conference presentation by Claire Gill, National Osteoporosis Foundation, and Brian Loew of Inspire, on topic of online patient support communities and how nonprofit patient advocacy organizations are leveraging members to help further their mission. Gill and Loew discussed how pharma companies can connect effectively with nonprofit patient advocacy organizations.
Scleroderma Foundation/Inspire Support Community at a Glance Inspire
The Scleroderma Foundation/Inspire Support Community is the peer-to-peer resource for support and inspiration for people affected by the rare disease scleroderma.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
3. What is Spontaneous Coronary Artery Dissection?
3
Source: Mayo Clinic
n Loew
ianloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org
8. Searching online for answers
From: <name>@aol.com [mailto:<name>@aol.com]
Sent: Wednesday, May 19, 2004 10:01 PM
To: KAKLeon@verizon.net
Subject: Re: postpartum dissection
Katherine,
I am glad to hear that your test results were good. Melissa has
talked to several women that have had this same problem. I have
the e-mail address of a few of them. I will give your name and e-
mail address to them so that you all can talk. I don't think you
will mind will you? I will also send you the e-mail addresses I
have. I know how important it is to be able to talk to each
other. Maybe Melissa will have her computer up and working in a
week or two.
Good Luck,
<name>
Lubbock, TX
n Loew
anloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org
9. And still searching
n Loew
anloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org
11. Growth of SCAD members
11
Katherine Leon makes
concrete connections
with others with SCAD
n Loew
anloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org
12. Growth of SCAD members
12
Laura Haywood-Cory posts
“All the SCAD Ladies”
Katherine Leon makes
concrete connections
with others with SCAD
WomenHeart partners
with Inspire
n Loew
anloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org
13. A researcher heeds the call
13
n Loew
anloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org
14. Growth of SCAD members
14
Laura Haywood-Cory posts
“All the SCAD Ladies”
Katherine Leon makes
concrete connections
with others with SCAD
Dr. Sharonne Hayes
launches pilot research
n Loew
anloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org
16. 16
Initial findings
From Mayo Clinic Proceedings
September, 2011
CONCLUSION
Our pilot demonstrates successful social
networking-enabled research participant
engagement and recruitment among members
of an international disease-specific online
community and outlines a novel methodology
to obtain retrospective and prospective data
from persons with uncommon, poorly
understood conditions. Our pilot serves as a
model as we develop a more extensive,
much-needed retrospective and prospective
study of SCAD. This process of recruiting
research trial participants with self-identified
conditions from social networking Internet
sites represents a mechanism to develop a
novel “multicenter disease registry” that could
be replicated to study and propel medical
advances in other uncommon conditions that
may not otherwise be subjects of active
investigation.
n Loew
anloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org
17. Growth of SCAD members
17
Laura Haywood-Cory posts
“All the SCAD Ladies”
Katherine Leon makes
concrete connections
with others with SCAD
Dr. Sharonne Hayes
launches pilot research
Initial Mayo findings published
n Loew
anloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org
18. 18
The future
Sharonne Hayes, MD, Mayo Clinic
n Loew
anloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org
19. In conclusion
19
Value is created by patients like Katherine -- not (only)
through ‘traditional’ channels.
Many patients want to contribute to research, but
patients need better pathways to access researchers.
Technology matters a great deal.
Technology doesn’t matter at all.
n Loew
anloew
n@inspire.com
Katherine Leon @katherinekleon
katherine@scadresearch.org